Martin Auster - Dec 18, 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Chief Financial Officer
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol: VTYX
Transactions as of: Dec 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/19/2023, 05:21 PM
Previous filing: Sep 7, 2023
Next filing: Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (right to buy)	Award	$0	+181K		$0.00	181K	Dec 18, 2023	Common Stock	181K	$2.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following December 18, 2023 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider, as defined in the Company's 2021 Equity Incentive Plan (the "Plan") through each such date.

Content

One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following December 18, 2023 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider, as defined in the Company's 2021 Equity Incentive Plan (the "Plan") through each such date.